Soleno Therapeutics, Inc. Stock
Stocks
SLNO
US8342033094
Biotechnology & Medical Research
|
Delayed
Nasdaq
16:00:00 2026-05-15 EDT
|
5-day change | 1st Jan Change | ||
| 53.01 USD | +0.04% |
|
-.--% | +14.49% |
| 06-15 | Soleno Therapeutics Announces Late-Breaking Data At Endo 2026 | CI |
| 05-19 | Soleno Therapeutics, Inc.(NasdaqGM:) dropped from Russell Small Cap Comp Growth Benchmark | CI |
| Market Cap | 2.76B 2.39B 2.25B 2.05B 3.85B 264B 3.91B 26.43B 10.32B 132B 10.37B 10.15B 440B | P/E 2024 |
-10.3x | P/E 2025 | 119x |
|---|---|---|---|---|---|
| Enterprise Value | 2.31B 2B 1.88B 1.71B 3.22B 220B 3.27B 22.09B 8.63B 110B 8.67B 8.48B 368B | EV / Sales 2024 |
-
| EV / Sales 2025 | 10,678,497x |
| Free-Float |
98.88% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Soleno Therapeutics, Inc.
| 1 day | +0.04% | ||
| 3 months | +0.15% | ||
| 6 months | +37.22% | ||
| Current year | +14.49% |
| Current year | 29.43 |  | 53.01 |
| 1 year | 29.43 | | 81.35 |
| 3 years | 3.69 | | 90.32 |
| 5 years | 0.85 | | 90.32 |
| 10 years | 0.85 | | 99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darin Lippoldt
PSD | President | 61 | 2026-05-14 |
| Treasurer | 46 | 2026-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Darin Lippoldt
BRD | Director/Board Member | 61 | 2026-05-14 |
| Director/Board Member | 46 | 2026-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/18/26 | Issuer sale | Sr. VP of Clinical Development | -175,523 | 0.3400% | ||
| 5/18/26 | Issuer sale | Director | -33,404 | 0.0647% | ||
| 1/21/26 | Free | Chief Financial Officer | 61,400 | 0.1155% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.04% | -.--% | -36.41% | +1,016.00% | 2.76B | |
| +2.07% | +10.05% | +77.41% | +106.53% | 70.1B | |
| -0.87% | +0.08% | +36.96% | +65.04% | 54.93B | |
| -3.42% | -4.40% | +3.13% | +468.23% | 28.89B | |
| +0.04% | +12.56% | +54.67% | +5.47% | 23.9B | |
| +0.04% | +1.85% | -17.64% | -13.55% | 23.3B | |
| +0.35% | +8.24% | +252.94% | +466.50% | 18.41B | |
| -0.59% | +7.88% | +40.87% | -20.12% | 18.77B | |
| -0.57% | +6.85% | +30.20% | +580.70% | 16.1B | |
| +0.94% | -2.75% | +31.89% | +136.01% | 12.48B | |
| Average | -0.17% | +7.38% | +47.40% | +281.08% | 26.96B | |
| Weighted average by Cap. | +0.02% | +7.95% | +54.33% | +172.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 190.4 165.04 154.72 141.07 265.44 18.17K 269.69 1.82K 711.2 9.1K 714.84 699.36 30.35K |
| Net income | -176M -152M -143M -130M -245M -16.78B -249M -1.68B -657M -8.4B -660M -646M -28.03B | 20.89M 18.11M 16.97M 15.48M 29.12M 1.99B 29.59M 200M 78.03M 998M 78.43M 76.73M 3.33B |
| Net Debt | -266M -230M -216M -197M -371M -25.37B -377M -2.54B -993M -12.7B -998M -976M -42.36B | -454M -393M -369M -336M -632M -43.29B -642M -4.34B -1.69B -21.67B -1.7B -1.67B -72.28B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SLNO Stock
Select your edition
All financial news and data tailored to specific country editions
